Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents
The GH/IGF-1 System and Cancer Risk For several decades there has been an accumulation of data from epidemiological studies, basic science research and studies related to patient groups with altered levels of GH/IGF-1 which has suggested that the GH/IGF-1 system may be associated with either tumourigenesis or more aggressive behaviour in cancers (Werner et al., 2019)
Transcriptome analysis reveals the efficacy of ginsenoside-rg1 in the treatment of nonalcoholic fatty liver disease
What are the key benefits of glutathione supplements for men
Curr Opin Genet Dev 7:7579 Bourne HR, Sanders DA, McCormick F (1991) The GTPase superfamily: conserved structure and molecular mechanism

Increased risks of heart attacks: Hormone treatments (e.g., testosterone) increase the risk of heart attack, stroke, and blood clots.Cancer risk: Long-term use of growth hormone or sex hormones may raise the risk of certain cancers (e.g., breast, prostate).Mood changes: Hormone imbalance can lead to mood swings, anxiety, or depression.Illegal use: Some medications, like human growth hormone (HGH), are illegal for anti-ageing use and carry legal risks.Poor regulation of compounded drugs: Compounded drugs are not a standardised product, appear to carry some risk of contamination, possibly present in the wrong dosage, and potentially contain harmful additives.No proven long-term benefit: Many anti-ageing treatments show little or only temporary benefit, and the long-term safety of such treatments is unknown.Misleading marketing: Treatments are often marketed with claims that greatly exceed any support from scientific research.Also read | Struggling with weak nails